Terms: = Colorectal cancer AND PR, PGR, progesterone receptor
1161 results:
1. Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis.
Huang Z; Li C; Huang Y; Liang W; Tao H
Front Immunol; 2024; 15():1425596. PubMed ID: 39100666
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of immunohistochemistry in patients with endometrial cancer.
Anca-Stanciu MB; Manu A; Olinca MV; Coroleucă BC; Comandaşu DE; Coroleucă CA; Maier C; Brătilă E
Rom J Morphol Embryol; 2024; 65(2):185-193. PubMed ID: 39020532
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the response to neoadjuvant chemoradiation for rectal cancer using nomograms based on MRI tumour regression grade.
Qin S; Chen Y; Liu K; Li Y; Zhou Y; Zhao W; Xin P; Wang Q; Lu S; Wang H; Lang N
Cancer Radiother; 2024 Aug; 28(4):341-353. PubMed ID: 38981746
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Chen H; Zhang JH; Hao Q; Wu XL; Guo JX; Huang CX; Zhang J; Xing GS; An ZL; Ling Y; Zhao JG; Bao YN
Int J Colorectal Dis; 2024 Jun; 39(1):99. PubMed ID: 38926205
[TBL] [Abstract] [Full Text] [Related]
5. Racial/Ethnic Disparities in HRQoL and Associated Risk Factors in colorectal cancer Survivors: With a Focus on Social Determinants of Health (SDOH).
Han CJ; Tounkara F; Kalady MF; Noonan AM; Paskett ED; Von Ah D
J Gastrointest Cancer; 2024 Sep; 55(3):1179-1189. PubMed ID: 38819610
[TBL] [Abstract] [Full Text] [Related]
6. Multilevel analysis of social determinants of advanced stage colorectal cancer diagnosis.
Dantas AAG; de Oliveira NPD; Costa GAB; Martins LFL; Dos Santos JEM; Migowski A; de Camargo Cancela M; de Souza DLB
Sci Rep; 2024 Apr; 14(1):9667. PubMed ID: 38671078
[TBL] [Abstract] [Full Text] [Related]
7. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
8. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
[TBL] [Abstract] [Full Text] [Related]
9. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
[TBL] [Abstract] [Full Text] [Related]
10. Long-Term Outcomes of Self-Expandable Metallic Stents as a Bridge to Surgery for Obstructive and Symptomatic Primary Tumors of Stage IV colorectal cancer: A Propensity-Score Analysis.
Sekioka A; Ota S; Ito T; Mizukami Y; Tsuboi K; Okamura M; Lee Y; Ishida S; Shim Y; Adachi Y
J Laparoendosc Adv Surg Tech A; 2024 Jul; 34(7):561-567. PubMed ID: 38574310
[No Abstract] [Full Text] [Related]
11. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
[TBL] [Abstract] [Full Text] [Related]
12. Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: clinical and molecular characteristics and survival.
Boysen ML; Troelsen FS; Sørensen HT; Erichsen R
Cancer Causes Control; 2024 Jul; 35(7):1043-1052. PubMed ID: 38483686
[TBL] [Abstract] [Full Text] [Related]
13. Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Corcoran RB; Do KT; Kim JE; Cleary JM; Parikh AR; Yeku OO; Xiong N; Weekes CD; Veneris J; Ahronian LG; Mauri G; Tian J; Norden BL; Michel AG; Van Seventer EE; Siravegna G; Camphausen K; Chi G; Fetter IJ; Brugge JS; Chen H; Takebe N; Penson RT; Juric D; Flaherty KT; Sullivan RJ; Clark JW; Heist RS; Matulonis UA; Liu JF; Shapiro GI
Clin Cancer Res; 2024 May; 30(9):1739-1749. PubMed ID: 38456660
[TBL] [Abstract] [Full Text] [Related]
14. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
[TBL] [Abstract] [Full Text] [Related]
15. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
[TBL] [Abstract] [Full Text] [Related]
16. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
17. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
Kikuchi K; Ogawa M; Sasaki A
J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
[TBL] [Abstract] [Full Text] [Related]
18. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank.
Zeng C; Schlueter DJ; Tran TC; Babbar A; Cassini T; Bastarache LA; Denny JC
J Am Med Inform Assoc; 2024 Apr; 31(4):846-854. PubMed ID: 38263490
[TBL] [Abstract] [Full Text] [Related]
20. The enigma of incisional hernia prediction unraveled: external validation of a prognostic model in colorectal cancer patients.
Amro C; Smith L; Shulkin J; McGraw JR; Hill N; Broach RB; Torkington J; Fischer JP
Hernia; 2024 Apr; 28(2):547-553. PubMed ID: 38227093
[TBL] [Abstract] [Full Text] [Related]
[Next]
